Guided Therapeutics (GTHP) Depreciation and Depletion (2014 - 2025)
Guided Therapeutics (GTHP) reported Depreciation and Depletion of $3000.0 for Q4 2025, up 50.0% on a YoY basis from $2000.0 in Q4 2024, and up 50.0% sequentially from $2000.0 in Q3 2025.
Guided Therapeutics (GTHP) Depreciation and Depletion (2014 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 6 years of Depreciation and Depletion data on file, last reported at $3000.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation and Depletion rose 50.0% year-over-year to $3000.0; the trailing twelve-month figure through Dec 2025 stood at $10000.0 (up 11.11% YoY), and the FY2025 full-year result was $10000.0, up 11.11% from the prior year.
- Depreciation and Depletion grew to $3000.0 in Q4 2025, from $2000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $3000.0 in Q4 2022 to a low of $1000.0 in Q3 2022.
- A 4-year average of $2285.7 and a median of $2000.0 in 2023 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 100.0% in 2023, while the deepest fall reached 33.33% in 2023.
- Tracing GTHP's Depreciation and Depletion over 4 years: stood at $3000.0 in 2022, then sank by 33.33% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then jumped by 50.0% to $3000.0 in 2025.
- Business Quant data shows GTHP's Depreciation and Depletion at $3000.0 in Q4 2025, $2000.0 in Q3 2025, and $3000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |